FDA Approves 1st Drug For GCA, Puma Leaps, Will SBPH Spring A Surprise?

Today's Daily Dose brings you news about the spike in Puma's shares ahead of FDA panel review; FDA approval of expanded indication of Roche's subcutaneous Actemra; FDA approval of Sanofi's Kevzara; upcoming catalyst of Spring Bank Pharma and secondary offering of GlycoMimetics.

from RTT - Biotech http://ift.tt/2rbDzy4
via IFTTT